DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Wagg A, Arumi D, Herschorn S. et al.
A pooled analysis of the efficacy of fesoterodine for the treatment of overactive bladder, and the relationship between safety, co-morbidity and polypharmacy in patients aged 65 years or older.
Age Ageing 2017;
46: 620-626
Access:
We do not assume any responsibility for the contents of the web pages of other providers.